Magnus Christensen

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Magnus Christensen's trades of Cinclus Pharma Holding publ AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SE Medivir AB (MVIR-B)
Transaction date
Purchase
Price
63.74
Quantity 73,413
Value SEK3,448,323
SE Medivir AB (MVIR-B)
Transaction date
Purchase
Price
2.94
Quantity 15,000
Value SEK44,100
SE Medivir AB (MVIR-B)
Transaction date
Purchase
Price
2.65
Quantity 38,000
Value SEK100,700
SE Medivir AB (MVIR-B)
Transaction date
Purchase
Price
7.34
Quantity 17,000
Value SEK124,780
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-18 2026-05-15
B Purchase
54,646
200.23
SEK4,003,128 		54,646 200.23 SEK4,003,128
2026-04-09 2026-04-07
B Purchase
91,564
184.79
SEK4,845,009 		91,564 184.79 SEK4,845,009
2025-12-03 2025-12-02
SE Medivir AB (MVIR-B)
B Purchase
73,413
63.74
SEK3,448,323 		73,413 63.74 SEK3,448,323
2024-05-30 2024-05-29
SE Medivir AB (MVIR-B)
B Purchase
15,000
2.94
SEK44,100 		15,000 2.94 SEK44,100
2023-12-22 2023-12-22
SE Medivir AB (MVIR-B)
B Purchase
38,000
2.65
SEK100,700 		38,000 2.65 SEK100,700
2023-05-16 2023-05-16
SE Medivir AB (MVIR-B)
B Purchase
17,000
7.34
SEK124,780 		17,000 7.34 SEK124,780